The results suggested that RREs may inhibit the proliferation and apoptosis of HCC cells by inducing ROS production, decreasing Bcl-2/Bax ratio, and significantly decreasing mitochondrial membrane potential of HepG2 cells, thus inhibiting the progression of HCC. Here, BCL2 is linked to hepatocellular carcinoma.